Entering text into the input field will update the search result below

Generic Drug Stocks

Jul. 28, 2013 5:26 PM ETHSP, TEVA
Activist Stocks profile picture
Activist Stocks's Blog
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Be sure to check out our detailed stock analysis (click here). IMS Health pegs the worldwide generic drug market at an impressive $240 billion, which should only grow over the long-term as a large number of branded drugs lose patent protection -- pushing the total generic drug market to over $420 billion in 2016.

Other key factors driving generic market growth will be a rapidly aging population and the healthcare reform in he U.S., which will give more people access to prescription drug benefits. This is offering investors an impressive investing opportunity. So what are some of the best ways to capitalize on this?


Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.